BeyondSpring (BYSI) Operating Expenses (2016 - 2026)
BeyondSpring (BYSI) posted Operating Expenses of $2.2 million for Q1 2026, down 14.02% sequentially from $2.6 million in Q4 2025, and down 14.48% YoY from $2.6 million in Q1 2025.
BeyondSpring (BYSI) Operating Expenses (2016 - 2026) Analysis & Trends
BeyondSpring has reported Operating Expenses for 9 years, with the latest figure at $2.2 million in Q1 2026.
- Quarterly Operating Expenses fell 14.48% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 7.97% YoY) and the FY2025 annual result came in at $8.9 million, up 2.18% from the prior year.
- Operating Expenses retreated to $2.2 million in Q1 2026 per BYSI's latest filing, from $2.6 million in the prior quarter.
- Over five years, Operating Expenses peaked at $2.6 million in Q2 2024 and troughed at $1.7 million in Q4 2024.
- A 3-year average of $2.2 million and a median of $2.2 million in 2026 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 52.71% in 2025, down 26.2% in 2025.
- Over 3 years, Operating Expenses stood at $1.7 million in 2024, then surged by 52.71% to $2.6 million in 2025, then decreased by 14.02% to $2.2 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $2.2 million, $2.6 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2021 | 10.83 Mn |
| Sep 30, 2021 | 18.69 Mn |
| Jun 30, 2021 | 20.32 Mn |
| Mar 31, 2021 | 17.76 Mn |
| Dec 31, 2020 | 18.80 Mn |
| Sep 30, 2020 | 15.35 Mn |
| Jun 30, 2020 | 13.62 Mn |
| Mar 31, 2020 | 16.63 Mn |
| Dec 31, 2019 | 15.29 Mn |
| Sep 30, 2019 | 9.70 Mn |